$RNG
RingCentral, Inc.

2023 Q2 Form 10-Q Financial Statement

#000138490523000032 Filed on August 07, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2022 Q4
Revenue $539.3M $524.7M
YoY Change 10.76% 17.0%
Cost Of Revenue $164.4M $160.6M
YoY Change 3.94% 18.07%
Gross Profit $374.9M $364.2M
YoY Change 14.05% 16.54%
Gross Profit Margin 69.51% 69.4%
Selling, General & Admin $339.7M $350.6M
YoY Change -0.08% 6.56%
% of Gross Profit 90.61% 96.27%
Research & Development $80.28M $88.76M
YoY Change -16.82% 2.29%
% of Gross Profit 21.41% 24.38%
Depreciation & Amortization $58.04M $62.40M
YoY Change 229.76% 32.56%
% of Gross Profit 15.48% 17.13%
Operating Expenses $420.0M $439.3M
YoY Change -3.78% 5.67%
Operating Profit -$45.06M -$75.16M
YoY Change -58.18% -27.21%
Interest Expense -$5.118M $375.1M
YoY Change -525.44% 2449.14%
% of Operating Profit
Other Income/Expense, Net $4.551M -$402.4M
YoY Change -108.98% 1201.91%
Pretax Income -$14.53M -$281.9M
YoY Change -90.83% 140.37%
Income Tax $6.953M $2.213M
% Of Pretax Income
Net Earnings -$21.48M -$284.1M
YoY Change -86.53% 140.01%
Net Earnings / Revenue -3.98% -54.13%
Basic Earnings Per Share -$0.23
Diluted Earnings Per Share -$0.23 -$2.97
COMMON SHARES
Basic Shares Outstanding 95.34M shares
Diluted Shares Outstanding 95.34M shares

Balance Sheet

Concept 2023 Q2 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $225.4M $270.0M
YoY Change -26.48% 1.06%
Cash & Equivalents $143.7M $270.0M
Short-Term Investments
Other Short-Term Assets $254.9M $31.33M
YoY Change 1219.09% 92.75%
Inventory $1.126M $1.209M
Prepaid Expenses $34.91M $23.31M
Receivables $322.2M $311.3M
Other Receivables $0.00 $0.00
Total Short-Term Assets $803.5M $796.0M
YoY Change 8.69% 22.32%
LONG-TERM ASSETS
Property, Plant & Equipment $217.1M $185.4M
YoY Change 21.83% 11.08%
Goodwill $54.58M $54.34M
YoY Change 1.48% -2.08%
Intangibles $457.4M $528.1M
YoY Change -27.22% -26.31%
Long-Term Investments $0.00 $4.559M
YoY Change -100.0% -97.83%
Other Assets $427.7M $31.29M
YoY Change 5904.82% 286.05%
Total Long-Term Assets $1.157B $1.278B
YoY Change -35.01% -33.74%
TOTAL ASSETS
Total Short-Term Assets $803.5M $796.0M
Total Long-Term Assets $1.157B $1.278B
Total Assets $1.960B $2.074B
YoY Change -22.19% -19.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $36.74M $62.72M
YoY Change -61.99% -10.43%
Accrued Expenses $308.4M $380.1M
YoY Change -3.1% 35.85%
Deferred Revenue $227.2M $209.7M
YoY Change 9.74% 18.86%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $20.00M $0.00
YoY Change
Total Short-Term Liabilities $592.4M $652.6M
YoY Change -4.76% 24.0%
LONG-TERM LIABILITIES
Long-Term Debt $1.559B $1.638B
YoY Change -4.73% 17.16%
Other Long-Term Liabilities $81.61M $45.85M
YoY Change 10.15% -45.45%
Total Long-Term Liabilities $1.640B $45.85M
YoY Change 2114.15% -45.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $592.4M $652.6M
Total Long-Term Liabilities $1.640B $45.85M
Total Liabilities $2.233B $2.357B
YoY Change -5.3% 15.5%
SHAREHOLDERS EQUITY
Retained Earnings -$1.610B -$1.534B
YoY Change 66.78% 104.91%
Common Stock $1.143B $1.060B
YoY Change 21.98% -2.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$272.4M -$482.8M
YoY Change
Total Liabilities & Shareholders Equity $1.960B $2.074B
YoY Change -22.19% -19.6%

Cashflow Statement

Concept 2023 Q2 2022 Q4
OPERATING ACTIVITIES
Net Income -$21.48M -$284.1M
YoY Change -86.53% 140.01%
Depreciation, Depletion And Amortization $58.04M $62.40M
YoY Change 229.76% 32.56%
Cash From Operating Activities $90.69M $39.37M
YoY Change 78.96% -17.37%
INVESTING ACTIVITIES
Capital Expenditures $17.81M $22.98M
YoY Change -174.86% -107.14%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$17.81M -$22.98M
YoY Change -25.14% -93.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$89.28M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -122.1M -53.44M
YoY Change 510.68% -125.66%
NET CHANGE
Cash From Operating Activities 90.69M 39.37M
Cash From Investing Activities -17.81M -22.98M
Cash From Financing Activities -122.1M -53.44M
Net Change In Cash -49.23M -37.04M
YoY Change -813.8% -52.36%
FREE CASH FLOW
Cash From Operating Activities $90.69M $39.37M
Capital Expenditures $17.81M $22.98M
Free Cash Flow $72.89M $16.40M
YoY Change -2.12% -95.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.79
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.27
CY2021 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate202006Member
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q2 us-gaap Interest Expense
InterestExpense
5118000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
1203000 usd
us-gaap Interest Expense
InterestExpense
7330000 usd
us-gaap Interest Expense
InterestExpense
2435000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-19658000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-167697000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-72297000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-320731000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-482787000 usd
CY2023Q1 rng Stock Issued During Period Value Employee Stock Purchase Plan Increase Decrease To Additional Paid In Capital
StockIssuedDuringPeriodValueEmployeeStockPurchasePlanIncreaseDecreaseToAdditionalPaidInCapital
-1641000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
42585000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
74776000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
97303000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1760000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-54399000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-471955000 usd
CY2023Q2 rng Stock Issued During Period Value Employee Stock Purchase Plan Increase Decrease To Additional Paid In Capital
StockIssuedDuringPeriodValueEmployeeStockPurchasePlanIncreaseDecreaseToAdditionalPaidInCapital
8542000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
12429000 usd
CY2022Q1 rng Stock Issued During Period Value Employee Stock Purchase Plan Increase Decrease To Additional Paid In Capital
StockIssuedDuringPeriodValueEmployeeStockPurchasePlanIncreaseDecreaseToAdditionalPaidInCapital
-120000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
98424000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2062000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-150972000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
48783000 usd
CY2022Q2 rng Stock Issued During Period Value Employee Stock Purchase Plan Increase Decrease To Additional Paid In Capital
StockIssuedDuringPeriodValueEmployeeStockPurchasePlanIncreaseDecreaseToAdditionalPaidInCapital
7827000 usd
CY2022Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
25004000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
98402000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-8182000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-159515000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-37689000 usd
us-gaap Net Income Loss
NetIncomeLoss
-75881000 usd
us-gaap Net Income Loss
NetIncomeLoss
-310487000 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
115556000 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
122201000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
202851000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
198119000 usd
rng Loss Gain And Other Related Costs On Investments
LossGainAndOtherRelatedCostsOnInvestments
98045000 usd
us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
65160000 usd
us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
50068000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2398000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2232000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
31107000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
rng Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
10175000 usd
rng Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
9857000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4940000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
7103000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-1632000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
1736000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
15813000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
27832000 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
62153000 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
108349000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2773000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1984000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-38890000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
28494000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
17459000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
20147000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
17486000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
30594000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-10198000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-10271000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
199224000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
109673000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13160000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15489000 usd
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
25964000 usd
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
26232000 usd
rng Payments To Acquire Intangible Assets And Long Term Investments
PaymentsToAcquireIntangibleAssetsAndLongTermInvestments
0 usd
rng Payments To Acquire Intangible Assets And Long Term Investments
PaymentsToAcquireIntangibleAssetsAndLongTermInvestments
3990000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-39124000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-45711000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
10887000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
10889000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3986000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3182000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
174570000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
25004000 usd
us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
394394000 usd
us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
0 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
427304000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
3291000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
3092000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
973000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1538000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-204843000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-21927000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
110000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2700000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-44633000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
39335000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
269984000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
267162000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
225351000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
306497000 usd
us-gaap Interest Paid Net
InterestPaidNet
3429000 usd
us-gaap Interest Paid Net
InterestPaidNet
220000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
7654000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1717000 usd
rng Issuance Of Common Stock In Connection With Commercial Arrangements
IssuanceOfCommonStockInConnectionWithCommercialArrangements
55014000 usd
rng Issuance Of Common Stock In Connection With Commercial Arrangements
IssuanceOfCommonStockInConnectionWithCommercialArrangements
0 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3452000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
9599000 usd
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
2997000 usd
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
0 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The significant estimates made by management affect revenues, the allowance for doubtful accounts, deferred and prepaid sales commission costs, goodwill, useful lives of intangible assets, share-based compensation, capitalization of internally developed software, return reserves, derivative instruments, provision for income taxes, uncertain tax positions, loss contingencies, sales tax liabilities and accrued liabilities. Management periodically evaluates these estimates and will make adjustments prospectively based upon the results of such periodic evaluations. Actual results may differ from these estimates.</span></div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2023 and December 31, 2022, none of the Company’s customers accounted for more than 10% of the Company’s total accounts receivable.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets by geographic location are based on the location of the legal entity that owns the asset. As of June 30, 2023 and December 31, 2022, approximately 94% of the Company’s consolidated long-lived assets were located in the U.S. No other single country outside of the U.S. represented more than 10% of the Company’s consolidated long-lived assets.</span></div>
CY2023Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
43000000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
169200000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2300000000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.53
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.47
CY2023Q2 us-gaap Cash
Cash
81690000 usd
CY2022Q4 us-gaap Cash
Cash
88153000 usd
CY2023Q2 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
143661000 usd
CY2022Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
181831000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
225351000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
269984000 usd
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
1100000 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
5500000 usd
CY2023Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
242947000 usd
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
242650000 usd
CY2023Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
90761000 usd
CY2022Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
78249000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
11517000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
9581000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
322191000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
311318000 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
34914000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
23306000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
1126000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1209000 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
49425000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
31334000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
85465000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
55849000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
483695000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
444195000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
297889000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
258795000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
185806000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
185400000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
20500000 usd
CY2022Q2 us-gaap Depreciation
Depreciation
17600000 usd
us-gaap Depreciation
Depreciation
40800000 usd
us-gaap Depreciation
Depreciation
34500000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
54335000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
240000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
54575000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
839691000 usd
CY2023Q2 rng Finite Lived Intangible Assets Accumulated Amortization And Impairment
FiniteLivedIntangibleAssetsAccumulatedAmortizationAndImpairment
382257000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
457434000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
835469000 usd
CY2022Q4 rng Finite Lived Intangible Assets Accumulated Amortization And Impairment
FiniteLivedIntangibleAssetsAccumulatedAmortizationAndImpairment
307418000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
528051000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
37500000 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
43700000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
74700000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
87700000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
74594000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
135159000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
134289000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
112980000 usd
CY2023Q2 rng Finite Lived Intangible Asset Expected Amortization After Year Three
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearThree
412000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
42175000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
53419000 usd
CY2023Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
39181000 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
37836000 usd
CY2023Q2 rng Accrued Marketing Costs And Sales Commission Current
AccruedMarketingCostsAndSalesCommissionCurrent
58667000 usd
CY2022Q4 rng Accrued Marketing Costs And Sales Commission Current
AccruedMarketingCostsAndSalesCommissionCurrent
127940000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
16992000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
17513000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
151387000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
143405000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
308402000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
380113000 usd
CY2023Q2 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
32900000 usd
CY2022Q2 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
26900000 usd
us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
65200000 usd
us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
50100000 usd
us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 usd
CY2023Q2 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 usd
CY2022Q2 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 usd
us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 usd
rng Capitalized Contract Cost Gain Recognized
CapitalizedContractCostGainRecognized
4500000 usd
CY2023Q2 us-gaap Supplier Finance Program Payment Timing Period
SupplierFinanceProgramPaymentTimingPeriod
P5Y
CY2023Q2 us-gaap Supplier Finance Program Obligation
SupplierFinanceProgramObligation
5800000 usd
CY2023Q2 us-gaap Supplier Finance Program Obligation Current
SupplierFinanceProgramObligationCurrent
3500000 usd
CY2023Q2 us-gaap Supplier Finance Program Obligation Noncurrent
SupplierFinanceProgramObligationNoncurrent
2300000 usd
CY2023Q2 us-gaap Derivative Assets
DerivativeAssets
5728000 usd
CY2023Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
2334000 usd
CY2022Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
1646000 usd
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1589296000 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1650000000 usd
CY2023Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
10502000 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
11589000 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
20000000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1558794000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1638411000 usd
CY2023Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
3286000 usd
CY2022Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
0 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
3286000 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
0 usd
CY2023Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1279000 usd
CY2022Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1116000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2398000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2232000 usd
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
4565000 usd
CY2022Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
1116000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
5684000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
2232000 usd
CY2023Q2 us-gaap Purchase Obligation
PurchaseObligation
19800000 usd
CY2023Q1 us-gaap Purchase Obligation
PurchaseObligation
124000000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
142000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
8000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
15.55
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P0Y3M18D
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
31339000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
35433000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
16992000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
17513000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
16596000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
20182000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
33588000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
37695000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
11197000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
11348000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
6089000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3804000 usd
CY2017Q2 us-gaap Loss Contingency Number Of Plaintiffs
LossContingencyNumberOfPlaintiffs
2 action
CY2020Q2 rng Loss Contingency Damages Sought Value Per Violation
LossContingencyDamagesSoughtValuePerViolation
5000 usd
CY2019Q3 rng Loss Contingency Cross Complaint Number Of Defendants
LossContingencyCrossComplaintNumberOfDefendants
2 defendent
CY2023Q2 rng Purchase Obligation Amount Outstanding
PurchaseObligationAmountOutstanding
117800000 usd
CY2023Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
175000000 usd
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
5500000 shares
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
175000000 usd
CY2023Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
125000000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
104660000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
100511000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
202851000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
198119000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
104660000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
100511000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
202851000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
198119000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
22000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.53
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y6M
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
509000 usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
14000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
10.75
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.55
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y3M18D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
142000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
8000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
15.55
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P0Y3M18D
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
142000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1800000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
13300000 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
0 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000000 usd
CY2023Q2 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
5000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-21482000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-159515000 usd
us-gaap Net Income Loss
NetIncomeLoss
-75881000 usd
us-gaap Net Income Loss
NetIncomeLoss
-310487000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
95339000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
95130000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
95528000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
94854000 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.68
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.68
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.79
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10488000 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4536000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8424000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4266000 shares
CY2023Q2 us-gaap Restructuring Costs
RestructuringCosts
3606000 usd
CY2022Q2 us-gaap Restructuring Costs
RestructuringCosts
1576000 usd
us-gaap Restructuring Costs
RestructuringCosts
8481000 usd
us-gaap Restructuring Costs
RestructuringCosts
2515000 usd
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
5485000 usd
us-gaap Restructuring Costs
RestructuringCosts
8481000 usd
us-gaap Payments For Restructuring
PaymentsForRestructuring
11422000 usd
CY2023Q2 us-gaap Restructuring Reserve
RestructuringReserve
2544000 usd
CY2023Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001384905-23-000032-index-headers.html Edgar Link pending
0001384905-23-000032-index.html Edgar Link pending
0001384905-23-000032.txt Edgar Link pending
0001384905-23-000032-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
rng-20230630.htm Edgar Link pending
rng-20230630.xsd Edgar Link pending
rng-20230630x10qxex101.htm Edgar Link pending
rng-20230630x10qxex311.htm Edgar Link pending
rng-20230630x10qxex312.htm Edgar Link pending
rng-20230630x10qxex321.htm Edgar Link pending
rng-20230630x10qxex322.htm Edgar Link pending
Show.js Edgar Link pending
rng-20230630_def.xml Edgar Link unprocessable
rng-20230630_lab.xml Edgar Link unprocessable
rng-20230630_pre.xml Edgar Link unprocessable
rng-20230630_htm.xml Edgar Link completed
rng-20230630_cal.xml Edgar Link unprocessable